No Photo Available

Last Update

2016-09-29T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Nancy Lurker?

Ms. Nancy S. Lurker

Chief Executive Officer

PDI , Inc.

Direct Phone: (862) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

PDI , Inc.

Morris Corporate Center 1, Building A 300 Interpace Parkway

Parsippany, New Jersey 07054

United States

Company Description

PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States through its Commercial Services busine ... more

Find other employees at this company (1,852)

Background Information

Employment History

Chief Executive Officer and President

ImpactRx , Inc.

Senior Director, Global CV Marketing

Bristol-Myers Squibb Company

Affiliations

Board Member
BroadOak Capital Partners LLC

Board Member
Medtronic , Inc.

Chief Executive Officer and A Member of the Board of Directors
Pharma Marketing Network

Education

B.S

Biology and Chemistry

University of Evansville

BS

biology

Seattle Pacific University

M.B.A.

University of Evansville ( Indiana )

MBA

University of Evansville

Web References (131 Total References)


Interpace Diagnostics Group, Inc. - 2015 News Releases

phx.corporate-ir.net [cached]

Nancy Lurker Resigns as CEO; Board Member Jack E. Stover Appointed Interim President, CEO Gerald P. Belle Retires as Chairman of Board of Directors; Succeeded by Stephen J. Sullivan Harry Glorikian and Dr. Joseph D. Keegan Appointed to Board of Directors PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(Nasdaq: PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as President, CEO and a member ...

...
Nancy Lurker Resigns as CEO; Board Member Jack E. Stover Appointed Interim President, CEO Gerald P. Belle Retires as Chairman of Board of Directors; Succeeded by Stephen J. Sullivan Harry Glorikian and Dr. Joseph D. Keegan Appointed to Board of Directors PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(Nasdaq: PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as President, CEO and a member ...
...
PARSIPPANY, N.J., March 5, 2015 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Nancy Lurker, the company's chief executive officer and Graham Miao, the company's chief financial officer, are scheduled to present at the 27th Annual ROTH Conference at 3:00 pm PT on March 10, 2015 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.


Nancy Lurker Ms. ...

phx.corporate-ir.net [cached]

Nancy Lurker Ms. Lurker joined us as Chief Executive Officer and a director in November 2008. Prior to joining PDI, Ms. Lurker was senior vice-president and chief marketing officer for Novartis Pharmaceuticals Corporation, the U.S. subsidiary of Novartis AG, where she oversaw a product portfolio in multiple therapeutic areas from 2006 to 2007. Prior to that, she was president and chief executive officer of ImpactRx, Inc. since 2003, a privately owned company offering among its services the evaluation of the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest prescribing physicians. From 2000 to 2003, Ms. Lurker served as group vice president-global primary care products for Pharmacia Corporation, where she led a business unit that commercialized drugs for urology, cardiovascular, central nervous system, respiratory and women's health. She was also a member of Pharmacia's U.S. executive management committee, the group responsible for managing all U.S.-based profits as well as all U.S. management policies. Earlier in her career, she was vice president for business development at National Physicians Corporation, an IPA risk management and practice management group. During her 14 years at Bristol-Myers Squibb, Ms. Lurker rose from senior sales representative at Mead Johnson to various product management and business development positions, ultimately becoming senior director-worldwide cardiovascular franchise management. Ms. Lurker received a B.S. in Biology with high honors from Seattle Pacific University and an M.B.A. from the University of Evansville in Evansville, Indiana.


PARSIPPANY, N.J., March 5, 2015 ...

phx.corporate-ir.net [cached]

PARSIPPANY, N.J., March 5, 2015 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Nancy Lurker, the company's chief executive officer and Graham Miao, the company's chief financial officer, are scheduled to present at the 27th Annual ROTH Conference at 3:00 pm PT on March 10, 2015 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.


PARSIPPANY, N.J., March 5, 2015 ...

phx.corporate-ir.net [cached]

PARSIPPANY, N.J., March 5, 2015 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Nancy Lurker, the company's chief executive officer and Graham Miao, the company's chief financial officer, are scheduled to present at the 27th Annual ROTH Conference at 3:00 pm PT on March 10, 2015 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.


"As we continue to execute on ...

phx.corporate-ir.net [cached]

"As we continue to execute on our strategic vision of solidifying a position in the molecular diagnostics space, we welcome John's unparalleled business expertise in this market," said Nancy Lurker, chief executive officer of PDI, Inc.

...
PARSIPPANY, N.J., March 5, 2013 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the ROTH Capital Partners 25th Annual Growth Stock Conference at 10:00 am PT on March 20, 2013 at the Ritz-Carlton Laguna Nigel in Dana Point, CA. The live webcast may be accessed under the "Investor Relations" tab on the company's website at http://www.pdi-inc.com. The webcast will be archived for 30 days. About PD...

Similar Profiles

Other People with this Name

Other people with the name Lurker

Andrew Lurker

Dana Lurker
Duncan Supply Company Inc

Andrew Lurker

Emily Lurker
Foremost Interiors

Scott Lurker
EmpiRx Health, LLC

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory